Cargando…

Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid

Aim: Bullous pemphigoid (BP) is an organ-specific autoimmune bullous disease characterized by autoantibodies that target the cellular adhesion molecules BP180 and BP230. Both immunoglobulin (Ig)G and IgE are involved in the induction of subepidermal blisters. Specifically, IgE autoantibodies are pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fangyuan, Wang, Yiman, Chen, Xinyi, Yang, Nan, Li, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Dermatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071969/ https://www.ncbi.nlm.nih.gov/pubmed/36999962 http://dx.doi.org/10.1080/07853890.2023.2188487

Ejemplares similares

When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
por: Hopkins, Christina R, et al.
Publicado: (2022)

Combination Therapy of Plasma Exchange and Rituximab to Treat Cicatricial Pemphigoid and Bullous Pemphigoid
por: Kunadia, Anuj, et al.
Publicado: (2021)

Dyshidrosiform Bullous Pemphigoid: Case Reports and Review
por: Cohen, Philip R
Publicado: (2020)

Delayed Onset of Bullous Pemphigoid Secondary to Nivolumab
por: Olsen, Eric, et al.
Publicado: (2023)

Hydrochlorothiazide vs Venlafaxine: Drug-induced Bullous Pemphigoid
por: Naramala, Srikanth, et al.
Publicado: (2019)

A Case of Bullous Pemphigoid Associated With Nivolumab Therapy
por: Gotera, Nico, et al.
Publicado: (2022)

Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
por: Shanshal, Mohammed
Publicado: (2022)

A Case of Severe Bullous Dermatitis With Mixed Bullous Pemphigoid and Pemphigus Vulgaris Cutaneous Manifestations
por: Burns, Reece D, et al.
Publicado: (2021)

Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine
por: Desai, Amar D, et al.
Publicado: (2022)

The Successful Treatment of COVID-19-Induced Bullous Pemphigoid With Dupilumab
por: Savoldy, Michelle A, et al.
Publicado: (2022)

A Case of Drug-Induced Bullous Pemphigoid With an Isomorphic Response and Updated Review of Koebnerization in Bullous Diseases
por: Ambur, Austin B, et al.
Publicado: (2021)

A Case of Bullous Pemphigoid: A Prevalent and Potentially Fatal Condition
por: Parellada, Jorge, et al.
Publicado: (2018)

Bullous Pemphigoid in a Centenarian Male Simulating Toxic Epidermal Necrolysis
por: Shakhashiro, Muna, et al.
Publicado: (2023)

Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid
por: Koga, Hiroshi, et al.
Publicado: (2023)

Bullous Pemphigoid: A Spontaneous Presentation in a Patient With Chronic Kidney Disease
por: Brazen, Brett, et al.
Publicado: (2022)

Association of Bullous Pemphigoid with Malignancy: A Myth or Reality?
por: Fernandes, Joycelin, et al.
Publicado: (2014)

Bullous Pemphigoid and Human Leukocyte Antigen (HLA)-DQA1: A Systematic Review
por: Hesari, Roksana, et al.
Publicado: (2023)

A Rare Case of Bullous Pemphigoid Secondary to Checkpoint Inhibitor Immunotherapy: A Tense Situation
por: Wesolow, Jacqueline T, et al.
Publicado: (2021)

A Case of Bullous Pemphigoid in a Five-Month-Old Female: A Rare Presentation
por: Ahmed, Mohamed, et al.
Publicado: (2023)

Bullous Pemphigoid Associated With Pembrolizumab Therapy for Non-Small-Cell Lung Cancer: A Case Report
por: Chatterjee, Tulika, et al.
Publicado: (2022)

Validation study of bullous pemphigoid and pemphigus vulgaris recording in routinely collected electronic primary healthcare records in England
por: Persson, Monica S M, et al.
Publicado: (2020)

Bullous Pemphigoid Limited to the Hands and Feet: A Rare Case of an Infantile Disease Pattern Seen in an Elderly Patient
por: Nellore, Aditya, et al.
Publicado: (2023)

Localized bullous pemphigoid: a case report
por: Wang, Yiman, et al.
Publicado: (2020)

IL-13 Genetic Susceptibility to Bullous Pemphigoid: A Potential Target for Treatment and a Prognostic Marker
por: Wang, Yiman, et al.
Publicado: (2022)

The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets
por: Maglie, Roberto, et al.
Publicado: (2023)

Relationship between bullous pemphigoid and metabolic syndrome: a 12-year case–control study conducted in China
por: Zhang, Bingjie, et al.
Publicado: (2022)

Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches
por: Toh, Wu Han, et al.
Publicado: (2023)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

Bullous Iodide Rash
Publicado: (1909)

A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets
por: Afarideh, Mohsen, et al.
Publicado: (2022)

Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)

The Hidden Cause of Maculopapular Rash in Interleukin-12 Deficiency
por: Altamimi, Abdullah M, et al.
Publicado: (2022)

Resolution in bullous pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019)

Esophageal Bullous Pemphigoid
por: Castelo Branco, Catarina, et al.
Publicado: (2022)

Dyshidrosiform Bullous Pemphigoid
por: Cohen, Philip R.
Publicado: (2021)

Assessment of the Characteristics and Associated Factors of Infectious Complications in Bullous Pemphigoid
por: Chen, Jia, et al.
Publicado: (2020)

Cutaneous Dermatophytosis Mimicking Bullous Pemphigoid or Typical Bullous Pemphigoid and Tinea Incognito?
por: Andrés, Tirado-Sánchez, et al.
Publicado: (2019)

Compartment Syndrome of the Hand Presenting as Bullous Edema
por: Braunlich, Phillip R, et al.
Publicado: (2020)

Bullous Pilomatrixoma After COVID-19 Vaccination
por: Alvarez-Rubio, Francisco Javier, et al.
Publicado: (2022)

Management of a Large Palatal Ulcer: Mucous Membrane Pemphigoid
por: Badki, Simran D, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nna5i5ol4t5lp59v5vs060j0ff